IL98133A - 2-alkyl-1, 2, 3, 4, 4a, 10b-hexahydro-6-(sulfonamidophenyl)-benzo-(c)-1, 6-naphthyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

2-alkyl-1, 2, 3, 4, 4a, 10b-hexahydro-6-(sulfonamidophenyl)-benzo-(c)-1, 6-naphthyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL98133A
IL98133A IL9813391A IL9813391A IL98133A IL 98133 A IL98133 A IL 98133A IL 9813391 A IL9813391 A IL 9813391A IL 9813391 A IL9813391 A IL 9813391A IL 98133 A IL98133 A IL 98133A
Authority
IL
Israel
Prior art keywords
compounds
denotes
alkyl
salts
methyl
Prior art date
Application number
IL9813391A
Other languages
English (en)
Other versions
IL98133A0 (en
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IL98133A0 publication Critical patent/IL98133A0/xx
Publication of IL98133A publication Critical patent/IL98133A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heat Treatment Of Steel (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9813391A 1990-05-16 1991-05-14 2-alkyl-1, 2, 3, 4, 4a, 10b-hexahydro-6-(sulfonamidophenyl)-benzo-(c)-1, 6-naphthyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same IL98133A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH165890 1990-05-16

Publications (2)

Publication Number Publication Date
IL98133A0 IL98133A0 (en) 1992-06-21
IL98133A true IL98133A (en) 1994-11-11

Family

ID=4215610

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9813391A IL98133A (en) 1990-05-16 1991-05-14 2-alkyl-1, 2, 3, 4, 4a, 10b-hexahydro-6-(sulfonamidophenyl)-benzo-(c)-1, 6-naphthyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Country Status (23)

Country Link
US (1) US5346904A (cs)
EP (1) EP0528922B1 (cs)
JP (1) JP3238397B2 (cs)
CN (1) CN1027507C (cs)
AT (1) ATE181330T1 (cs)
AU (1) AU651592B2 (cs)
CA (1) CA2082923C (cs)
CS (1) CS144791A3 (cs)
DE (3) DE4191109A1 (cs)
DK (1) DK0528922T3 (cs)
ES (1) ES2134777T3 (cs)
FI (1) FI925005A0 (cs)
GR (1) GR3031098T3 (cs)
HU (2) HU9203557D0 (cs)
IE (1) IE911625A1 (cs)
IL (1) IL98133A (cs)
MY (1) MY105344A (cs)
NO (1) NO924414D0 (cs)
NZ (1) NZ238141A (cs)
PT (1) PT97680B (cs)
WO (1) WO1991017991A1 (cs)
YU (1) YU85691A (cs)
ZA (1) ZA913627B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009780A1 (de) * 1991-11-15 1993-05-27 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von sulfonylverbindungen
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
SK283269B6 (sk) * 1996-11-11 2003-04-01 Altana Pharma Ag Benzonaftyridíny, farmaceutický prostriedok s ich obsahom a ich použitie
ATE248167T1 (de) * 1997-03-07 2003-09-15 Altana Pharma Ag Tetrazole derivate
AU8106598A (en) 1997-06-03 1998-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
AU729995B2 (en) 1997-06-30 2001-02-22 Nippon Kayaku Kabushiki Kaisha Novel naphthyridine derivatives or salts thereof
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US8196556B2 (en) * 2009-09-17 2012-06-12 Delphi Technologies, Inc. Apparatus and method for setting mechanical lash in a valve-deactivating hydraulic lash adjuster
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EA201391254A1 (ru) 2011-03-01 2014-02-28 Синерджи Фармасьютикалз Инк. Способ получения агонистов гуанилатциклазы c
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
DE2503156A1 (de) * 1974-02-05 1975-08-07 Sandoz Ag Verfahren zur herstellung neuer heterocyclischer verbindungen
US4087530A (en) * 1974-02-05 1978-05-02 Sandoz Ltd. Substituted 6-phenyl-octahydrobenzo [c] [1,6] naphthyridines
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin

Also Published As

Publication number Publication date
PT97680A (pt) 1992-02-28
AU651592B2 (en) 1994-07-28
IL98133A0 (en) 1992-06-21
CA2082923C (en) 2001-12-18
NO924414L (no) 1992-11-16
ZA913627B (en) 1992-01-29
YU85691A (sh) 1994-06-24
HUT62895A (en) 1993-06-28
CN1027507C (zh) 1995-01-25
JPH05507081A (ja) 1993-10-14
ES2134777T3 (es) 1999-10-16
PT97680B (pt) 1998-09-30
JP3238397B2 (ja) 2001-12-10
HU9203557D0 (en) 1993-03-29
NZ238141A (en) 1993-07-27
CN1056691A (zh) 1991-12-04
NO924414D0 (no) 1992-11-16
IE911625A1 (en) 1991-11-20
MY105344A (en) 1994-09-30
EP0528922A1 (de) 1993-03-03
ATE181330T1 (de) 1999-07-15
EP0528922B1 (de) 1999-06-16
DE59109135D1 (de) 1999-07-22
DE4191109D2 (en) 1993-04-01
FI925005A (fi) 1992-11-05
FI925005A0 (fi) 1992-11-05
GR3031098T3 (en) 1999-12-31
CS144791A3 (en) 1992-03-18
DE4191109A1 (cs) 1993-04-01
US5346904A (en) 1994-09-13
WO1991017991A1 (de) 1991-11-28
CA2082923A1 (en) 1991-11-17
AU7870191A (en) 1991-12-10
DK0528922T3 (da) 1999-11-22

Similar Documents

Publication Publication Date Title
CA2082923C (en) Sulfonyl compounds
US6025367A (en) Sulfonamide derivatives as 5HT7 receptor antagonists
US4083980A (en) Derivatives of quinazolone
SK31793A3 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines and piperazines and compositions and methods of use thereof
PL116532B1 (en) Process for preparing novel derivatives of amides of 2-methoxy-4-amino-5-alkylsulfonylbenzoic acid
CA1168232A (en) Isoquinoline derivatives, a process for their preparation, pharmaceutical formulations containing them and their use
WO1996011930A1 (en) Cns-active pyridinylurea derivatives
US4575508A (en) 2-Substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-β-carbolines, and their use as antiarrhythmic agents
US4277476A (en) Derivatives of fluorenes and fluoranthenes and process for their preparation
IE42978B1 (en) Triaryl alkyl azabicyclo compounds
JP2669468B2 (ja) ベンゾ―及びチエノ―３，４―ジヒドロピリジン誘導体、その製造方法及びこれらの化合物を含有する医薬組成物
EP0222474B1 (en) Gamma-carbolines
US5635511A (en) Treatment of heart rhythm disorders by administration of 3-phenylsulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds.
US3989709A (en) Fused ring benzimidazole derivatives
US4176184A (en) Imidazoisoquinoline-diones and salts thereof
EP0273176A2 (en) Fused heterocyclic tetrahydroaminoquinolinols and related compounds, a process for their preparation and their use as medicaments
EP0200450A2 (en) Tricyclic derivativesof thiadiazole oxides
CA1175428A (en) Process for preparing imidazo /1,2-a/ quinoline derivatives
HU210686B (en) Process for producing 3,7-diazobicyclo(3,3.1)nonan compounds and pharmaceutical compositions containing the same
US4771052A (en) Tetrahydropyrido[3',4':4,5]pyrrolo[2,3-c]quinolines and their use as hypotensive agents
KR850000126B1 (ko) 이미다졸 유도체의 제조방법
US4681881A (en) 5-alkoxy-pyrido[4,3-d]pyrimidine derivatives
WO2001036418A1 (en) Novel triazaspirodecanones with high affinity for opioid receptor subtypes
CA1138864A (en) 4-phenyl-4,5,6,7-tetrahydro-pyrrolo[2,3-c] pyridines, process for the production thereof and pharmaceutical compositions
US5059607A (en) Imidazolyl benzisoquinolines useful as 5-ht3 receptor antagonists

Legal Events

Date Code Title Description
RH Patent void